RM
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
36.862
Exchange
XNYS - New York Stock Exchange, Inc
27 %
Last period Net income growth rate
64%
Net income growth rate has increased in 5 years
What is Net income growth rate ?
An indicator of the company's profit growth rate relative to the same periods of previous years.
See also Resmed
Company Analysis
RMD valuation, rating, competitors, insights and company profile
Eyestock Rating
RMD financial analysis by Eyestock methodology
Valuation
RMD valuation using historical relative method
Statements
RMD Income Statements, Balance Sheet and Cash Flow Statements
Dividends
RMD dividend yield and annual dividend
An indicator of the company's profit growth rate relative to the same periods of previous years.
Resmed`s Net income growth rate for the period ended 2024-06-30 is 27 %
